[Interpretation of the North American Pediatric Aplastic Anemia Consortium's evidence-based treatment recommendations for newly diagnosed pediatric severe aplastic anemia (2024 edition)]

Zhonghua Er Ke Za Zhi. 2024 Nov 15;62(12):1151-1157. doi: 10.3760/cma.j.cn112140-20240727-00521. Online ahead of print.
[Article in Chinese]

Abstract

重型再生障碍性贫血(SAA)是一种免疫介导的骨髓衰竭综合征,其特征是全血细胞减少和骨髓增生低下。北美儿童再生障碍性贫血联盟(NAPAAC)发布的“新诊断儿童SAA的循证治疗建议(2024版)”为该病的治疗提供了明确的指导方针。本文对主要治疗策略进行解读,重点涵盖了同胞相合供者造血干细胞移植和免疫抑制治疗。.